SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950133-99-001350
Filing Date
1999-04-15
Accepted
1999-04-15 00:00:00
Documents
10
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 NOVAVAX, INC. FORM 10-K405 10-K405 146615
2 AMENDMENT TO STOCK OPTION PLAN EX-10.3 1077
3 AMENDED AND RESTATED EMPLOYMENT AGREEMENT EX-10.11 19935
4 EMPLOYMENT AGREEMENT DATED FEBRUARY 23, 1998 EX-10.12 19890
5 EMPLOYMENT AGREEMENT DATED MARCH 5,1998 EX-10.13 20292
6 EMPLOYMENT AGREEMENT DATED MARCH 31, 1998 EX-10.14 20682
7 SEPERATION AND RELEASE AGREEMENT EX-10.15 8919
8 STOCK AND WARRANT PURCHASE AGREEMENT EX-10.16 72302
9 CONSENT OF PRICEWATERHOUSECOOPERS LLP EX-23 673
10 FINANCIAL DATA SCHEDULE EX-27 2000
  Complete submission text file 0000950133-99-001350.txt   314865
Mailing Address 8320 GUILFORD ROAD SUITE C COLUMBIA MD 21046
Business Address 8320 GUILFORD RD SUITE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-26770 | Film No.: 99594677
SIC: 2836 Biological Products, (No Diagnostic Substances)